Detalhe da pesquisa
1.
Low stent thrombosis risk with the XIENCE V® Everolimus-Eluting Coronary Stent: evidence from randomized and single-arm clinical trials.
J Interv Cardiol
; 24(4): 326-41, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443551
2.
Performance of everolimus-eluting versus paclitaxel-eluting coronary stents in small vessels: results from the SPIRIT III and SPIRIT IV clinical trials.
J Interv Cardiol
; 24(6): 505-13, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21919955
3.
Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years.
Am J Cardiol
; 111(11): 1580-6, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23499270
4.
Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents.
EuroIntervention
; 7(9): 1030-42, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22207228
5.
Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years.
Am J Cardiol
; 110(1): 21-9, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22464212
6.
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions.
Circ Cardiovasc Interv
; 5(2): 150-6, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22438430
7.
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials.
EuroIntervention
; 8(1): 87-93, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22580252
8.
Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
EuroIntervention
; 7(3): 307-13, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21729832
9.
Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial).
Am J Cardiol
; 107(6): 841-8, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21255760
10.
Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial).
Am J Cardiol
; 107(6): 833-40, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21247538
11.
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.
JACC Cardiovasc Interv
; 3(12): 1220-8, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21232715
12.
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.
JACC Cardiovasc Interv
; 3(12): 1229-39, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21232716
13.
Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).
J Am Coll Cardiol
; 56(25): 2084-9, 2010 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21144968
14.
Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial.
EuroIntervention
; 6 Suppl J: J44-52, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21930490